chloroxine (capitrol) Report issue

Small molecule Approved FDA
ChEMBL DrugBank Drug Central Drugs@FDA KEGG MeSH PubChem repoDB

Active Ingredient History

NOW
  • Now
Chloroxine, a dichloroquinolinol, was first prepared by A. Hebebrand in 1888. It is an antibacterial drug that has been incorporated into shampoos to treat dandruff and seborrheic dermatitis. It has also been used internally as an antidiarrheal and in the lab as an analytical reagent. The drug was withdrawn from the market in the US by unknown reason.   NCATS

Chemistry

More Chemistry

Pharmacology

  • Mechanism of Action:
  • Multi-specific: Missing data
  • Black Box: No
  • Availability: Discontinued
  • Delivery Methods: Topical
  • Pro Drug: No

Alternative names

5,7-dichlor-8-hydroxychinolin | 5,7-dichloro-8-hydroxyquinoline | 5,7-dichloro-8-oxyquinoline | 5,7-dichloro-8-quinolinol | 5,7-dichlorooxine | 5,7-dichloroxine | capitol | capitrol | chlofucid | chloroxine | chloroxine hydrofluoride | chloroxyquinoline | chlorquinol | chq | clofuzid | dichlorohydroxyquinoline | dichloroquine | dichloroquinolinol | dichloroxin | endiaron | quixalin

Organizations (1)

Research & Development (0)

Organization Org Type FDA approvals Clinical Trials involvement Org ID Force Sort

Marketing (1)

Organization Org Type FDA approvals Clinical Trials involvement Org ID Force Sort

Indications (1)

Approved Indications (1)


 

Dermatitis, Seborrheic (approved 1976)

Experimental Indications - Clinical Trial Phases 1-4 (0)

Feedback

Data collection and curation is an ongoing process for CDEK - if you notice any information here to be missing or incorrect, please let us know! When possible, please include a source URL (we verify all data prior to inclusion).

Report issue